Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Bluejay Diagnostics (BJDX) Shares Outstanding (Weighted Average) (2021 - 2023)

Bluejay Diagnostics' Shares Outstanding (Weighted Average) history spans 3 years, with the latest figure at $2741.0 for Q4 2023.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 99.73% to $2741.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $2741.0, a 99.73% decrease, with the full-year FY2023 number at $271714.0, down 73.05% from a year prior.
  • Shares Outstanding (Weighted Average) hit $2741.0 in Q4 2023 for Bluejay Diagnostics, down from $137871.0 in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for BJDX hit a ceiling of $1.0 million in Q4 2022 and a floor of $2741.0 in Q4 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $160050.7 across 3 years, with a median of $75400.0 in 2023.
  • The widest YoY moves for Shares Outstanding (Weighted Average): up 3557.06% in 2023, down 99.73% in 2023.
  • Tracing BJDX's Shares Outstanding (Weighted Average) over 3 years: stood at $128438.0 in 2021, then surged by 684.97% to $1.0 million in 2022, then tumbled by 99.73% to $2741.0 in 2023.
  • Business Quant data shows Shares Outstanding (Weighted Average) for BJDX at $2741.0 in Q4 2023, $137871.0 in Q3 2023, and $3770.0 in Q2 2023.